???pagination.result.count???
???pagination.result.page???
1
ADAMTS9, a member of the ADAMTS family, in Xenopus development. , Desanlis I., Gene Expr Patterns. September 1, 2018; 29 72-81.
Xenopus ADAM19 regulates Wnt signaling and neural crest specification by stabilizing ADAM13. , Li J., Development. April 4, 2018; 145 (7):
Identification of genes expressed in the migrating primitive myeloid lineage of Xenopus laevis. , Agricola ZN., Dev Dyn. January 1, 2016; 245 (1): 47-55.
Targeting of retinal axons requires the metalloproteinase ADAM10. , Chen YY ., J Neurosci. August 1, 2007; 27 (31): 8448-56.
Xenopus ADAMTS1 negatively modulates FGF signaling independent of its metalloprotease activity. , Suga A., Dev Biol. July 1, 2006; 295 (1): 26-39.
Matrix metalloproteinases are required for retinal ganglion cell axon guidance at select decision points. , Hehr CL ., Development. August 1, 2005; 132 (15): 3371-9.
The cysteine-rich domain regulates ADAM protease function in vivo. , Smith KM ., J Cell Biol. December 9, 2002; 159 (5): 893-902.
Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration. , Alfandari D , Alfandari D ., Curr Biol. June 26, 2001; 11 (12): 918-30.
PACSIN2 is a regulator of the metalloprotease/ disintegrin ADAM13. , Cousin H ., Dev Biol. November 1, 2000; 227 (1): 197-210.
Neural crest-specific and general expression of distinct metalloprotease-disintegrins in early Xenopus laevis development. , Cai H., Dev Biol. December 15, 1998; 204 (2): 508-24.
ADAM 13: a novel ADAM expressed in somitic mesoderm and neural crest cells during Xenopus laevis development. , Alfandari D , Alfandari D ., Dev Biol. February 15, 1997; 182 (2): 314-30.